Clinical presentation and management of Fasciola hepatica infection: Single-center experience

Table 1 Demographic features and laboratory results for patients with hepatic phase and biliary phase fascioliasis

Variables	Hepatic phase (mean ± SD)	Biliary phase (mean ± SD)
Age (yr)	40 (19-79)1	41 (29-49)1
Gender (M/F)	(5/17)	(1/7)
Hb (g/dL)	12.5 ± 1.4	12.7 ± 1.57
WBC (n/mm3)	11862 ± 2829	8765 ± 1307
Eosinophil (% of total WBC count)	34.2 ± 16.2	14 ± 13.5
Plt (n/mm3)	290 ± 62	273 ± 70
ESR (mm/h)	48 ± 26	17 ± 12
ALT (U/dL)	44 ± 49	220 ± 217
AST (U/dL)	26 ± 9	260 ± 357
ALP (U/dL)	157 ± 65	166 ± 85
GGT (U/dL)	64 ± 40	226 ± 128
Total bilirubin (U/dL)	0.57 ± 0.32	1.65 ± 2.02

¹Age is represented using the median and range. Hb: Hemoglobin; WBC: White blood cell; Plt: Platelet; ESR: Erythrocyte sedimentation rate; ALT: Alanine aminotransferase (range, 10-40 U/L); AST: Aspartate aminotransferase (range, 10-35 U/L); GGT: γ glutamyl transferase (range, 9-64 U/L); ALP: Alkaline phosphatase (range, 40-150 U/L); Total bilirubin: range, 0.2-1.2 mg/dL; M: Male; F: Female.